Partnerships in Therapeutics Development

The process of bringing new therapeutic goods to market and to patients is all about partnerships – ARCS has collaborated closely with the TGA, the PEB and the PBAC, government departments and research networks in the development of two exciting Congress programs for 2010. Both programs are available here – read carefully before making your decisions - register NOW to take advantage of Earlybird and Group discounts.
Register

Sydney 2012 abstracts now open

April 27th, 2011

In 2012, we return to Darling Harbour for our biggest Congress of the year.

General Guidelines

The Sydney ARCS Scientific Congress (ASC) Committee encourages the submission of abstracts which are thought provoking and include the sharing of actual case studies to promote information exchange.  Abstracts should reflect contemporary issues and may be controversial and/or cutting edge.

Interested in submitted an abstract?

Abstracts are to be submitted in accordance with the general guidelines provided using the submission form and submitted by the 30th November 2011.

Click here for more details

Sydney Highlights

  • HIGHLIGHTS coming soon.

Sydney Sponsors

Gold

Silver

Bronze

Register

Leadership Forum News

June 16th, 2011

Details for the 2012 ARCS Leadership Forum are coming soon.

Stay tuned!!

Leadership Forum Highlights

  • More information coming soon

Sponsors

Gold

Silver

Bronze

Register

Canberra Congress

March 24th, 2011

The ARCS Annual Scientific Congress will be held at the National Convention Centre, Canberra on 15 – 16 September 2011. In 2010, more than 84 speakers and 500 attendees listened and learned in a neutral forum of the latest developments in the Therapeutic Industry.

 

Regulatory Highlights

  • A focus on ANZTPA, the vision and next steps for the transition
  • Update on multiple TGA reforms announced or pending
  • Packaging and Labelling changes in New Zealand.
  • A strong devices programme
  • A full GMP/quality programme.
  • Pharmacovigilance and Post-Market accountabilities from a Regulatory perspective.
  • Opportunity to meet with TGA colleagues, from various offices including Scientific Evaluation, Manufacturing Quality, Parliamentary and Strategic Support, Information Management, Product Review, Signal Investigation – Devices and Devices Authorisation.



    • Some of our keynote speakers are as follows:

  • Dr Rohan Hammett, National Manager, TGA
  • Dr Stewart Jessamine, Group Manager, Medsafe, NZ



    • Other International Speakers include:

  • Tor Graberg, Chief Pharmaceutical Inspector, Medical Products Agency, Sweden
  • Michael Arnold, Global Business Process Head, Pfizer
  • And over 13 TGA speakers covering topics relevant to personnel involved in submissions to the department.

    • Canberra Sponsors

    Gold

    Silver

    Bronze

    © Copyright 2012 ARCS Australia